slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 38,881-38,910
Pages 10,126
Rows per page 30
Component
38,881-38,910 of 303,780
01
Genprex | Investor Presentation Deck | 39 slidesGenprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 2 hits
03
Genprex | Investor Presentation Deck | 39 slidesGenprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 2 hits
04
The slide uses a side-by-side comparison framework to highlight two major therapeutic areas.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 2 hits
06
Features a scientist standing in front of a whiteboard with diagrams.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 2 hits
07
The slide uses a mix of epidemiological data and commercial benchmarks to validate the market size.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Market Size2 hits
12
The slide uses a visual process flow to explain the mechanism of action for a biotech product.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Solution2 hits
13
Includes PET scan imagery showing metabolic response in a patient.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction2 hits
14
The table displays patient-level outcomes including response type, prior therapy history, and number of prior lines of therapy.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction2 hits
18
The slide uses a Kaplan-Meier survival plot to illustrate therapeutic efficacy.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction2 hits
19
The slide uses bioluminescence imaging and bar charts to show immune cell activation (T cells, NK cells, MDSC, DC) in response to treatment.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction2 hits
20
The slide presents two charts: a line chart showing tumor progression over time and a bar chart showing tumor intensity at week 4.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction2 hits
24
Genprex | Investor Presentation Deck | 39 slidesGenprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 2 hits
26
The slide uses a pie chart to illustrate the market split between Type 1 and Type 2 diabetes.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 2 hits
29
Includes a scientific diagram illustrating the alpha-to-beta cell reprogramming process.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 2 hits
31
The slide lists four key executives with their titles and professional highlights.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Team2 hits
32
The slide highlights key leadership roles in IP, manufacturing, HR, and regulatory affairs.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Team2 hits
33
The slide specifically highlights the Scientific Advisory Board rather than the executive management team.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Team2 hits
34
The slide specifically highlights the Clinical Advisory Board rather than the executive management team.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Team2 hits
35
The slide lists five individuals with their titles and professional backgrounds.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Team2 hits
29
The slide uses a timeline to establish the long-standing nature of the problem and positions the new therapy as a transformative solution.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 2 hits
30
Includes a diagram illustrating the biological process of alpha-to-beta cell reprogramming.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 2 hits
36
Genprex | Investor Presentation Deck | 44 slidesGenprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Action2 hits
37
The slide highlights the company management team with headshots and bulleted professional summaries.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Action2 hits
38
The slide specifically highlights the Scientific Advisory Board rather than the core management team.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Action2 hits
39
The slide specifically highlights the Clinical Advisory Board rather than the executive management team.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Action2 hits
40
The slide lists 5 individuals, one of whom has a placeholder for a photo.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Action2 hits
05
The diagram uses a bullseye/concentric circle framework to show the hierarchy from disease down to the molecular level.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 2 hits
06
The slide uses a numbered process flow to map the stages of collagen production, highlighting specific steps where CypB is involved using red circles.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 2 hits
07
The slide uses a three-part visual breakdown to map drug targets to therapeutic outcomes.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 2 hits
08
The slide uses a callout bubble to emphasize the consistency of findings across all listed models.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 2 hits